| Literature DB >> 31966451 |
Yuan He1, Jianfeng Zhong2, Shian Huang2, Xiaorong Shui3, Danli Kong4, Can Chen1,2, Wei Lei1,2.
Abstract
Acute myocardial infarction (AMI) therapy has not remarkably improved due to delay in the diagnosis to a great extent. Circulating microRNAs have shown some potential for diagnosis of cardiovascular diseases. The aim of this study was to estimate the diagnostic value of circulating miR-126-3p for AMI. In our study, circulating miR-126-3p levels were determined by quantitative polymerase chain reaction and the results showed it was 106-fold higher than that in controls, and elevated miR-126-3p was associated with aging through logistic correlation analyses. Receiver-operator characteristic curve was used to evaluate the sensitivity and specificity of miR-126-3p for diagnosis of AMI, indicating that its diagnostic effect was superior to the current clinical markers such as CK, CK-MB, hs-TnI, and MYO. Our results indicate that miR-126-3p in circulation is a potential novel diagnostic biomarker for AMI. IJCEPEntities:
Keywords: Acute myocardial infarction; biomarker; diagnosis; miR-126-3p; microRNA
Year: 2017 PMID: 31966451 PMCID: PMC6965822
Source DB: PubMed Journal: Int J Clin Exp Pathol ISSN: 1936-2625